Transversus Abdominis Plane (TAP) Block for Cesarean Section

NCT ID: NCT01015807

Last Updated: 2017-10-23

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-11-30

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether a transversus abdominis plane (TAP) block with Clonidine added to the injectate (Clo-TAP) performed approximately 2hrs after the cesarean section (CS) will decrease the amount of postoperative hyperalgesia and ultimately reduce post-CS chronic pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute severe pain after cesarean section (CS) occurs more often than is thought and 10-15% of the women having a cesarean section develop chronic pain (Kehlet et al. 2006). With over 1.3 million cesarean deliveries per year in the US, this is bound to create a significant health problem. One way to address this health burden is to refine techniques that may help control the pain women experience after CS and ultimately reduce the potential to develop chronic pain.

The purpose of this randomized, double-blinded study is to evaluate the ability of an established anesthetic technique called the transversus abdominis plane (TAP) block to reduce the amount of hyperalgesia women develop around their incision after CS. Measuring the amount of punctuate mechanical hyperalgesia is used as a tool to assess postoperative central sensitization (Lavand'homme et al. 2005), which contributes to postoperative acute pain. Since postoperative acute pain has been shown to be predictive of developing postoperative chronic pain (Eisenach et al. 2008; Yarnitsky et al. 2008), an effective TAP block could help diminish the incidence of chronic pain after CS. In addition, blood samples will be collected for future genetic analysis and we will test preoperatively for mechanical temporal summation (mTS) to evaluate CNS (central nervous system) sensitization and nociceptive system hyperexcitability and see if this correlates with the amount of hyperalgesia women develop around their incision after surgery.

The primary aim of this study is to evaluate the benefits of two different solutions injected by TAP block technique on postoperative peri-incisional hyperalgesia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperalgesia, Secondary

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

postoperative hyperalgesia pain transversus abdominis plane block TAP block cesarean section

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Sterile Saline used for TAP block = Bupivacaine Placebo + Clonidine Placebo

Group Type PLACEBO_COMPARATOR

Bupivacaine Placebo

Intervention Type DRUG

2 x 20mL 0.9% NaCl

Clonidine Placebo

Intervention Type DRUG

2 x 1mL 0.9% NaCl

TAP (Bupi)

2x20mL 0.375% Bupivacaine + 2x1mL of 0.9% NaCl = 150mg Bupivacaine + Clonidine Placebo

Group Type ACTIVE_COMPARATOR

Clonidine Placebo

Intervention Type DRUG

2 x 1mL 0.9% NaCl

Bupivacaine

Intervention Type DRUG

2 x 20mL 0.375% Bupivacaine = 150 mg Bupivacaine

Clo-TAP (Bupi + Clon)

2x20mL 0.375% Bupivacaine + 2x1mL Clonidine = 150mg Bupivacaine + 150µg Clonidine

Group Type ACTIVE_COMPARATOR

Bupivacaine

Intervention Type DRUG

2 x 20mL 0.375% Bupivacaine = 150 mg Bupivacaine

Clonidine

Intervention Type DRUG

2 x 1ml Clonidine = 150 µg Clonidine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacaine Placebo

2 x 20mL 0.9% NaCl

Intervention Type DRUG

Clonidine Placebo

2 x 1mL 0.9% NaCl

Intervention Type DRUG

Bupivacaine

2 x 20mL 0.375% Bupivacaine = 150 mg Bupivacaine

Intervention Type DRUG

Clonidine

2 x 1ml Clonidine = 150 µg Clonidine

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Bupi Placebo Sodium Chloride Sodium Chloride Bupivacaine Hydrochloride Clonidine Hydrochloride

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* non-laboring women who will benefit from and have clinically consented to a scheduled or non-scheduled cesarean delivery under spinal anesthesia
* English speaking (UW Site) or Portuguese speaking (Brazil site)
* aged between 18 and 45 years
* BMI \< 40
* ASA physical status class I or II

Exclusion Criteria

* laboring women undergoing a non-scheduled cesarean delivery
* non-English speaking (UW Site) or non-Portuguese speaking (Brazil site)
* previous spinal surgery
* contraindications for neuraxial anesthesia
* allergy to local anesthetic, ultrasound conduction gel, or Clonidine
* history of chronic pain
* inability to receive intraoperative Toradol
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Washington

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Laurent Bollag

Assistant Professor, Department of Anesthesiology and Pain Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ruth Landau, MD

Role: STUDY_CHAIR

University of Washington

Laurent Bollag, MD

Role: PRINCIPAL_INVESTIGATOR

University of Washington

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Washington

Seattle, Washington, United States

Site Status

Hospital e Maternidade Santa Joana

São Paulo, , Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Brazil

References

Explore related publications, articles, or registry entries linked to this study.

Buchanan ML, Easterling TR, Carr DB, Shen DD, Risler LJ, Nelson WL, Mattison DR, Hebert MF. Clonidine pharmacokinetics in pregnancy. Drug Metab Dispos. 2009 Apr;37(4):702-5. doi: 10.1124/dmd.108.024984. Epub 2008 Dec 30.

Reference Type BACKGROUND
PMID: 19116263 (View on PubMed)

Carvalho B, Angst MS, Fuller AJ, Lin E, Mathusamy AD, Riley ET. Experimental heat pain for detecting pregnancy-induced analgesia in humans. Anesth Analg. 2006 Nov;103(5):1283-7. doi: 10.1213/01.ane.0000239224.48719.28.

Reference Type BACKGROUND
PMID: 17056970 (View on PubMed)

Duma A, Urbanek B, Sitzwohl C, Kreiger A, Zimpfer M, Kapral S. Clonidine as an adjuvant to local anaesthetic axillary brachial plexus block: a randomized, controlled study. Br J Anaesth. 2005 Jan;94(1):112-6. doi: 10.1093/bja/aei009. Epub 2004 Oct 29.

Reference Type BACKGROUND
PMID: 15516351 (View on PubMed)

Eisenach JC, De Kock M, Klimscha W. alpha(2)-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995). Anesthesiology. 1996 Sep;85(3):655-74. doi: 10.1097/00000542-199609000-00026. No abstract available.

Reference Type BACKGROUND
PMID: 8853097 (View on PubMed)

Gabriel JS, Gordin V. Alpha 2 agonists in regional anesthesia and analgesia. Curr Opin Anaesthesiol. 2001 Dec;14(6):751-3. doi: 10.1097/00001503-200112000-00024.

Reference Type BACKGROUND
PMID: 17019175 (View on PubMed)

Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006 May 13;367(9522):1618-25. doi: 10.1016/S0140-6736(06)68700-X.

Reference Type BACKGROUND
PMID: 16698416 (View on PubMed)

Landau R, Schiffer E, Morales M, Savoldelli G, Kern C. The dose-sparing effect of clonidine added to ropivacaine for labor epidural analgesia. Anesth Analg. 2002 Sep;95(3):728-34, table of contents. doi: 10.1097/00000539-200209000-00036.

Reference Type BACKGROUND
PMID: 12198061 (View on PubMed)

Lavand'homme P. Postcesarean analgesia: effective strategies and association with chronic pain. Curr Opin Anaesthesiol. 2006 Jun;19(3):244-8. doi: 10.1097/01.aco.0000192815.22989.61.

Reference Type BACKGROUND
PMID: 16735805 (View on PubMed)

Lavand'homme P. Perioperative pain. Curr Opin Anaesthesiol. 2006 Oct;19(5):556-61. doi: 10.1097/01.aco.0000245284.53152.1f.

Reference Type BACKGROUND
PMID: 16960491 (View on PubMed)

Lavand'homme P, De Kock M, Waterloos H. Intraoperative epidural analgesia combined with ketamine provides effective preventive analgesia in patients undergoing major digestive surgery. Anesthesiology. 2005 Oct;103(4):813-20. doi: 10.1097/00000542-200510000-00020.

Reference Type BACKGROUND
PMID: 16192774 (View on PubMed)

Lavand'homme PM, Roelants F, Waterloos H, Collet V, De Kock MF. An evaluation of the postoperative antihyperalgesic and analgesic effects of intrathecal clonidine administered during elective cesarean delivery. Anesth Analg. 2008 Sep;107(3):948-55. doi: 10.1213/ane.0b013e31817f1595.

Reference Type BACKGROUND
PMID: 18713912 (View on PubMed)

Lavand'homme PM, Roelants F, Waterloos H, De Kock MF. Postoperative analgesic effects of continuous wound infiltration with diclofenac after elective cesarean delivery. Anesthesiology. 2007 Jun;106(6):1220-5. doi: 10.1097/01.anes.0000267606.17387.1d.

Reference Type BACKGROUND
PMID: 17525598 (View on PubMed)

Marhofer P, Greher M, Kapral S. Ultrasound guidance in regional anaesthesia. Br J Anaesth. 2005 Jan;94(1):7-17. doi: 10.1093/bja/aei002. Epub 2004 Jul 26.

Reference Type BACKGROUND
PMID: 15277302 (View on PubMed)

McCartney CJ, Duggan E, Apatu E. Should we add clonidine to local anesthetic for peripheral nerve blockade? A qualitative systematic review of the literature. Reg Anesth Pain Med. 2007 Jul-Aug;32(4):330-8. doi: 10.1016/j.rapm.2007.02.010.

Reference Type BACKGROUND
PMID: 17720118 (View on PubMed)

McDonnell JG, Curley G, Carney J, Benton A, Costello J, Maharaj CH, Laffey JG. The analgesic efficacy of transversus abdominis plane block after cesarean delivery: a randomized controlled trial. Anesth Analg. 2008 Jan;106(1):186-91, table of contents. doi: 10.1213/01.ane.0000290294.64090.f3.

Reference Type BACKGROUND
PMID: 18165577 (View on PubMed)

McDonnell JG, Laffey JG. Transversus abdominis plane block. Anesth Analg. 2007 Sep;105(3):883. doi: 10.1213/01.ane.0000268542.45107.79. No abstract available.

Reference Type BACKGROUND
PMID: 17717264 (View on PubMed)

McDonnell JG, O'Donnell BD, Farrell T, Gough N, Tuite D, Power C, Laffey JG. Transversus abdominis plane block: a cadaveric and radiological evaluation. Reg Anesth Pain Med. 2007 Sep-Oct;32(5):399-404. doi: 10.1016/j.rapm.2007.03.011.

Reference Type BACKGROUND
PMID: 17961838 (View on PubMed)

Mendez R, Eisenach JC, Kashtan K. Epidural clonidine analgesia after cesarean section. Anesthesiology. 1990 Nov;73(5):848-52. doi: 10.1097/00000542-199011000-00009.

Reference Type BACKGROUND
PMID: 2240674 (View on PubMed)

Nikolajsen L, Sorensen HC, Jensen TS, Kehlet H. Chronic pain following Caesarean section. Acta Anaesthesiol Scand. 2004 Jan;48(1):111-6. doi: 10.1111/j.1399-6576.2004.00271.x.

Reference Type BACKGROUND
PMID: 14674981 (View on PubMed)

Ohel I, Walfisch A, Shitenberg D, Sheiner E, Hallak M. A rise in pain threshold during labor: a prospective clinical trial. Pain. 2007 Nov;132 Suppl 1:S104-S108. doi: 10.1016/j.pain.2007.05.007. Epub 2007 Jun 20.

Reference Type BACKGROUND
PMID: 17583429 (View on PubMed)

Pan PH, Coghill R, Houle TT, Seid MH, Lindel WM, Parker RL, Washburn SA, Harris L, Eisenach JC. Multifactorial preoperative predictors for postcesarean section pain and analgesic requirement. Anesthesiology. 2006 Mar;104(3):417-25. doi: 10.1097/00000542-200603000-00007.

Reference Type BACKGROUND
PMID: 16508387 (View on PubMed)

Parker RK, Connelly NR, Lucas T, Serban S, Pristas R, Berman E, Gibson C. Epidural clonidine added to a bupivacaine infusion increases analgesic duration in labor without adverse maternal or fetal effects. J Anesth. 2007;21(2):142-7. doi: 10.1007/s00540-006-0476-8. Epub 2007 May 30.

Reference Type BACKGROUND
PMID: 17458641 (View on PubMed)

Weissman-Fogel I, Granovsky Y, Crispel Y, Ben-Nun A, Best LA, Yarnitsky D, Granot M. Enhanced presurgical pain temporal summation response predicts post-thoracotomy pain intensity during the acute postoperative phase. J Pain. 2009 Jun;10(6):628-36. doi: 10.1016/j.jpain.2008.12.009. Epub 2009 Apr 23.

Reference Type BACKGROUND
PMID: 19398382 (View on PubMed)

Yarnitsky D, Crispel Y, Eisenberg E, Granovsky Y, Ben-Nun A, Sprecher E, Best LA, Granot M. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain. 2008 Aug 15;138(1):22-28. doi: 10.1016/j.pain.2007.10.033. Epub 2008 Jan 8.

Reference Type BACKGROUND
PMID: 18079062 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

36707

Identifier Type: -

Identifier Source: org_study_id